UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour (Q36624402)
scientific article published on October 2002
Language:
(P31) (Q13442814)
(P304) 1006-1012
(P407) (Q1860)
(P433) 9
(P478) 87
(P577) Tuesday, October 1, 2002
(P1433) (Q326309)
(P1476) "UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour" (language: en)
(P2093) N Tsuda
Y Nonaka
S Shichijo
A Yamada
M Ito
Y Maeda
M Harada
T Kamura
K Itoh
(P2860) (Q34530496)
(Q28209452)
(Q34126543)
(Q30655292)
(Q40623531)
(Q22253206)
(Q36375683)
(Q33753570)
(Q28143032)
(Q24314961)
(Q24647420)
(Q24312048)
(Q24680097)
(Q40612811)
(Q40587473)
(Q36365751)
(Q39667254)
(Q24319940)
(Q48158297)
(Q53996039)
(Q55476324)
(Q48303492)
(Q71129109)
(Q74105734)
(Q77437482)
(Q77959433)
(Q74052343)
(Q73098841)
(Q77372795)
(Q77666885)
(Q68828643)
(Q70156307)
other details
description scientific article published on October 2002

External Links